These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 39117006

  • 21. Polymyalgia rheumatica is a risk factor for more recalcitrant disease in giant cell arteritis: A retrospective cohort study.
    Moreel L, Betrains A, Boeckxstaens L, Molenberghs G, Van Laere K, De Langhe E, Vanderschueren S, Blockmans D.
    Semin Arthritis Rheum; 2024 Oct; 68():152499. PubMed ID: 38968729
    [Abstract] [Full Text] [Related]

  • 22. Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review.
    Sharma A, Mohammad AJ, Turesson C.
    Semin Arthritis Rheum; 2020 Oct; 50(5):1040-1048. PubMed ID: 32911281
    [Abstract] [Full Text] [Related]

  • 23. Differences in clinical manifestations and prognosis of Chinese giant cell arteritis patients with or without polymyalgia rheumatica.
    Zhang Y, Wang D, Chu X, Zhang W, Zeng X.
    Ir J Med Sci; 2019 May; 188(2):713-720. PubMed ID: 30251177
    [Abstract] [Full Text] [Related]

  • 24. Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review.
    Liozon E, Parreau S, Filloux M, Dumonteil S, Gondran G, Bezanahary H, Ly KH, Fauchais AL.
    Autoimmun Rev; 2021 Feb; 20(2):102732. PubMed ID: 33326851
    [Abstract] [Full Text] [Related]

  • 25. Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment.
    Belkhir R, Burel SL, Dunogeant L, Marabelle A, Hollebecque A, Besse B, Leary A, Voisin AL, Pontoizeau C, Coutte L, Pertuiset E, Mouterde G, Fain O, Lambotte O, Mariette X.
    Ann Rheum Dis; 2017 Oct; 76(10):1747-1750. PubMed ID: 28600350
    [Abstract] [Full Text] [Related]

  • 26. Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.
    van Sleen Y, Graver JC, Abdulahad WH, van der Geest KSM, Boots AMH, Sandovici M, Brouwer E.
    Front Immunol; 2019 Oct; 10():1981. PubMed ID: 31507597
    [Abstract] [Full Text] [Related]

  • 27. [Polymyalgia rheumatica and Giant Cell Arteritis - Update on Diagnosis and Therapy].
    Becker M.
    Praxis (Bern 1994); 2020 Oct; 109(5):347-354. PubMed ID: 32233763
    [Abstract] [Full Text] [Related]

  • 28. Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice.
    Lally L, Spiera R.
    Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):803-812. PubMed ID: 31427056
    [Abstract] [Full Text] [Related]

  • 29. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
    Martinez-Taboada VM, Bartolome MJ, Fernandez-Gonzalez MD, Blanco R, Rodriguez-Valverde V, Lopez-Hoyos M.
    Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
    [Abstract] [Full Text] [Related]

  • 30. Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.
    Gonzalez-Gay MA, Garcia-Porrua C, Miranda-Filloy JA, Martin J.
    Drugs Aging; 2006 Sep; 23(8):627-49. PubMed ID: 16964987
    [Abstract] [Full Text] [Related]

  • 31. Giant cell arteritis and polymyalgia rheumatica: an update.
    González-Gay MA, Pina T.
    Curr Rheumatol Rep; 2015 Feb; 17(2):6. PubMed ID: 25618572
    [Abstract] [Full Text] [Related]

  • 32. Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?
    Salvarani C, Padoan R, Iorio L, Tomelleri A, Terrier B, Muratore F, Dasgupta B.
    Autoimmun Rev; 2024 Jan; 23(1):103415. PubMed ID: 37625672
    [Abstract] [Full Text] [Related]

  • 33. Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica.
    De Miguel E, Karalilova R, Macchioni P, Ponte C, Conticini E, Cowley S, Tomelleri A, Monti S, Monjo I, Batalov Z, Klinowski G, Falsetti P, Kane DJ, Campochiaro C, Hočevar A.
    Ann Rheum Dis; 2024 Feb 15; 83(3):335-341. PubMed ID: 37932008
    [Abstract] [Full Text] [Related]

  • 34. Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis.
    Matteson EL, Buttgereit F, Dejaco C, Dasgupta B.
    Rheum Dis Clin North Am; 2016 Feb 15; 42(1):75-90, viii. PubMed ID: 26611552
    [Abstract] [Full Text] [Related]

  • 35. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.
    Askling J, Klareskog L, Hjalgrim H, Baecklund E, Björkholm M, Ekbom A.
    Ann Rheum Dis; 2005 Dec 15; 64(12):1765-8. PubMed ID: 15843445
    [Abstract] [Full Text] [Related]

  • 36. Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis.
    Bahlas S, Ramos-Remus C, Davis P.
    J Rheumatol; 1998 Jan 15; 25(1):99-104. PubMed ID: 9458211
    [Abstract] [Full Text] [Related]

  • 37. Diagnosis and management of polymyalgia rheumatica.
    Jones O, Birrell F.
    Practitioner; 2016 Dec 15; 260(1799):13-6. PubMed ID: 29020715
    [Abstract] [Full Text] [Related]

  • 38. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Unizony S, Arias-Urdaneta L, Miloslavsky E, Arvikar S, Khosroshahi A, Keroack B, Stone JR, Stone JH.
    Arthritis Care Res (Hoboken); 2012 Nov 15; 64(11):1720-9. PubMed ID: 22674883
    [Abstract] [Full Text] [Related]

  • 39. Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations.
    Unizony S, McCulley TJ, Spiera R, Pei J, Sidiropoulos PN, Best JH, Birchwood C, Pavlov A, Stone JH.
    Arthritis Res Ther; 2021 Jan 06; 23(1):8. PubMed ID: 33407817
    [Abstract] [Full Text] [Related]

  • 40. Review of phase 2/3 trials in polymyalgia rheumatica and giant cell arteritis.
    Nageswaran P, Ahmed S, Tahir H.
    Expert Opin Emerg Drugs; 2024 Mar 06; 29(1):5-17. PubMed ID: 38180809
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.